Safety and preliminary efficacy of the Gam-COVID-Vac vaccine and outcomes of SARS-CoV-2 infection in Russian patients with genitourinary malignancies

BACKGROUND: To our knowledge, there is no clinical data pertaining to COVID-19 outcomes and safety of COVID-19 vaccination in Russian patients with genitourinary (GU) malignancies. Aim of our analysis was to describe the characteristics of the COVID-19 infection course as well as preliminary safety...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsimafeyeu, Ilya, Volkova, Maria, Alekseeva, Galina, Berkut, Maria, Nosov, Alexander, Myslevtsev, Igor, Andrianov, Andrey, Semenov, Andrey, Borisov, Pavel, Zukov, Ruslan, Goutnik, Vadim, Savchuk, Sergey, Dengina, Natalia, Mitin, Timur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590125/
https://www.ncbi.nlm.nih.gov/pubmed/34774086
http://dx.doi.org/10.1186/s13045-021-01205-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590125/
https://www.ncbi.nlm.nih.gov/pubmed/34774086
http://dx.doi.org/10.1186/s13045-021-01205-z

Ejemplares similares